Product Information
CLOBETASOL 0.05% SOLUTION is a generic product labeled by E. Fougera & Co. a division of Fougera Pharmaceuticals Inc., priced at $0.1359 per ML under NDC 00168026950. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on Feb 8, 1999. Its Orange Book therapeutic-equivalence code is AT.
Strength
.5 mg/mL
NDC
00168026950
Classification
Generic
Dosage Form
SOLUTION
Route
TOPICAL
Effective Date
9/23/2026
Active Ingredients
CLOBETASOL PROPIONATEApproval Type
Generic (ANDA)
FDA Application
ANDA075391FDA Approved
2/8/1999
TE Code
AT
On Market Since
2/8/1999
Pharmacological Classes
Price Statistics
The NADAC for CLOBETASOL 0.05% SOLUTION has been published 671 times since Nov 28, 2013, and over the history we have for it it has declined 34.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1359 per ML |
|---|---|
| All-time high | $2.7504 (Mar 11, 2015) |
| All-time low | $0.1149 (May 20, 2026) |
| 52-week high | $0.1829 |
| 52-week low | $0.1149 |
| Median price | $0.4933 |
| Average price | $0.7986 |
| Largest weekly change | +1203.9% (Sep 10, 2014) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Clobetasol Propionate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
E. Fougera & Co. a division of Fougera Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Clobetasol Propionate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Corticosteroid class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CLOBETASOL 0.05% SOLUTION?
The current National Average Drug Acquisition Cost (NADAC) for CLOBETASOL 0.05% SOLUTION, manufactured by E. Fougera & Co. a division of Fougera Pharmaceuticals Inc., is $0.1359 per ML (NDC 00168026950), effective Sep 30, 2026.
How has the price of CLOBETASOL 0.05% SOLUTION changed over time?
Over the history we have for it, the NADAC for CLOBETASOL 0.05% SOLUTION has declined 34.0%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for CLOBETASOL 0.05% SOLUTION?
Since Nov 28, 2013, the NADAC for CLOBETASOL 0.05% SOLUTION has ranged from a low of $0.1149 (May 20, 2026) to a high of $2.7504 (Mar 11, 2015), with a median of $0.4933 per ML.
Are there cheaper alternatives to CLOBETASOL 0.05% SOLUTION?
No other NADAC-published product currently shares the active ingredient and strength of CLOBETASOL 0.05% SOLUTION in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures CLOBETASOL 0.05% SOLUTION?
CLOBETASOL 0.05% SOLUTION (NDC 00168026950) is labeled by E. Fougera & Co. a division of Fougera Pharmaceuticals Inc., and CMS classifies it as a generic product.